In an 80-year-old man with worsening memory, a Mini‑Mental State Examination (MMSE) score of 25/30, and normal laboratory studies, should the initial recommendation be a structured exercise program rather than pharmacologic therapy?

Recommendation for 80-Year-Old Man with Mild Cognitive Impairment

Both a structured exercise program AND pharmacologic therapy with a cholinesterase inhibitor should be initiated simultaneously for this patient with mild cognitive impairment (MMSE 25/30). This dual approach maximizes potential benefits for cognition, function, and quality of life.

Clinical Context and Diagnosis

An MMSE score of 25/30 indicates mild cognitive impairment (MCI) or very mild dementia 1. While the MMSE is widely used, it has known limitations in detecting MCI and may underestimate mild deficits 2. However, combined with the clinical history of "worsening memory," this score warrants immediate intervention.

Pharmacologic Intervention

Initiate a cholinesterase inhibitor (donepezil, galantamine, or rivastigmine) now 1. The evidence is clear:

• Cholinesterase inhibitors are recommended for mild to moderate dementia across international guidelines (UK, US, China, Japan) 1
• These medications delay clinical decline, benefit cognitive function, and reduce symptoms like memory loss and confusion 1
• Pharmacological treatment should be initiated regardless of frailty status in older adults with dementia 3
• Early intervention is critical—all patients continue to decline over time, but medications can slow this progression 4

Important Caveat

Monitor closely for side effects, particularly in an 80-year-old. For example, rivastigmine can cause dizziness and weight loss; evaluate whether cognitive benefits outweigh these risks 3. If ineffective or causing substantial adverse effects after adequate trial, consider switching agents or discontinuing.

Exercise Prescription (Equally Important)

Prescribe an individualized multicomponent physical exercise program immediately 3. This is not optional—exercise has Level 1B evidence for people living with dementia 5.

Specific Exercise Protocol

The most recent 2025 guidelines 3 provide precise parameters:

Aerobic Exercise:

• 10-20 minutes per session
• 3-7 days per week
• Intensity: 12-14 on Borg scale (55-70% heart rate reserve)

Resistance Exercise:

• 1-3 sets of 8-12 repetitions
• 2-3 days per week
• Start at 20-30% of one-repetition maximum, progress to 60-80%

Balance Training:

• 1-2 sets of 4-10 different exercises
• 2-7 days per week
• Target both static and dynamic postures

Gait Training:

• 5-30 minutes daily
• Focus on walking ability and endurance

Total Duration: 50-60 minutes daily, but can be distributed throughout the day to accommodate fatigue 3.

Why Exercise Matters

• Multicomponent exercise has benefits for both frailty and dementia 3
• Exercise provides sustained benefits for prevention of physical AND cognitive decline 3
• Non-pharmacologic interventions including physical exercise have positive impacts on cognition and physical function 1
• Interventions to manage frailty reduce overall dementia burden (Level 1B evidence) 5

Implementation Strategy

• Ideally involve a physical therapist or physical activity expert 3
• Tailor to the patient's physical and cognitive functioning 3
• Emphasize long-term adherence—benefits require sustained participation 3
• Provide additional support: reminders, caregiver involvement to improve adherence 3

Additional Non-Pharmacologic Interventions

Beyond exercise, recommend:

• Cognitive stimulation activities: reading, playing chess, music therapy 1
• Mediterranean diet: nuts, berries, green leafy vegetables, fish 1
• Social engagement: critical for reducing dementia burden 5
• Cognitive training programs when accessible 5

Common Pitfalls to Avoid

1. Don't delay medication waiting to "see if exercise works"—both interventions work through different mechanisms and should be started together
2. Don't prescribe vague "stay active" advice—provide the specific exercise parameters above
3. Don't use MMSE alone for ongoing monitoring—it has limited sensitivity for mild changes 2. Consider MoCA for better MCI detection 6
4. Avoid anticholinergic medications that could worsen cognition 5
5. Don't assume the patient can self-implement exercise—at age 80 with cognitive impairment, structured support is essential

Monitoring and Follow-up

• Reassess cognitive, functional, and neuropsychiatric symptoms periodically during medication use 1
• Monitor medication safety, tolerability, and effectiveness closely given age and potential frailty 3
• Track exercise adherence and adjust program as needed
• Screen for depression, which affects 40-50% of patients with dementia and impacts outcomes 3

The evidence strongly supports that medication alone or exercise alone is insufficient—this patient needs both interventions started now to optimize outcomes for morbidity, mortality, and quality of life.